PPT-Gender-specific Results of Atrial Fibrillation Ablation in

John M Mandrola MD Vicky A Swift APRN Kathryn Grace Thorne MS Sean Kettring David E Mann MD Baptist Hospital East Louisville KY No Author has any disclosures   Abstract Introduction. Date. Jaret Tyler, MD. Clinical Cardiac Electrophysiologist. Assistant Professor of Medicine. Ohio State’s Heart and Vascular Center. Atrial Fibrillation:. How Your “Type” Affects Your Treatment. John M Mandrola, MD, Vicky A Swift, APRN, Kathryn Grace Thorne, MS, Sean . Kettring. , David E Mann, MD. Baptist Hospital East, Louisville, KY. .. No Author has any disclosures.  . Abstract. Introduction. Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Con.. Amr Kamal, M.D. Alexandria Main University Hospital. Alexandria- Egypt. ECRA 2010. General Rules . In order to consider AF ablation as a first line therapy, we should have clear and evidence based answers for the following 5 questions:. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . Dott. Giovanni Carreras. U.O.S.Aritmologia . Ospedale S. Maria . Terni. . • The most common significant heart rhythm disturbance. • Incidence increases with age and the development of structural heart disease . Analyses Using CMS data. Susan R. Heckbert, MD, PhD. University of Washington. Analyses using CMS data. Methods. Strengths & limitations. Application in MESA. Applications outside . MESA. Medicare 5% sample, 100% sample. Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH. David MacLennan. NHS Lothian/Fife. South East Scotland Deanery. Nassir F. Marrouche, MD. , Oussama . Wazni. , MD, Tom Greene, PhD, J Michael Dean, MD, Eugene . Kholmovski. , PhD, Moussa Mansour, MD, Hugh Calkins, MD, Francis . Marchlinski. , MD, David Wilber, MD, Gerhard .